Patients unfit for Lasik can benefit from implanted phakic copolymer lens

Objective: To assess visual outcomes and safety of implantable phakic copolymer lenses (IPCLs)V2 model in patients with moderate to high myopia. Methodology: This prospective interventional cross-sectional study involving 40 eyes of 27 patients who had IPCL implantation for correction of myopic and myopic-astigmatism was carried out at Dar Al-salam private eye hospital, Baghdad from 1st May 2017 to 1st May 2020. Pre-operative and post-operative parameters included visual acuity by logMAR system, refraction, detailed examination by slit lamp bio microscopy, dilated fundus examination, intraocular pressure measurement, anterior chamber depth measurement by a pentacam in addition to white-to-white diameter measurement preoperatively. All had IPCL implantation and follow-up period was 12 months. Results: We found that 26 (96.3%) patients are happy to extremely satisfied with the procedure. BCVA was 0.275 logMAR preoperatively. Uncorrected visual acuity (UCVA) in the follow-up period was 0.035, which was considerably better than preoperative (BCVA). All patients had the same or improved VA post-operatively and remained stable during follow-up. The mean residual was -0.06 D. (min-1.37-max0.37). Conclusion: IPCL V2 used for correction of high ametropia resulted in a highly significant improvement in postoperative uncorrected visual acuity with minimal controllable complications and excellent patient’s satisfaction.